Hidekatsu Iha

1.6k total citations
49 papers, 1.2k citations indexed

About

Hidekatsu Iha is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Hidekatsu Iha has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Immunology and 7 papers in Oncology. Recurrent topics in Hidekatsu Iha's work include T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (6 papers) and NF-κB Signaling Pathways (6 papers). Hidekatsu Iha is often cited by papers focused on T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (6 papers) and NF-κB Signaling Pathways (6 papers). Hidekatsu Iha collaborates with scholars based in Japan, United States and Malaysia. Hidekatsu Iha's co-authors include Kuan‐Teh Jeang, Yoichi Iwanaga, Takefumi Kasai, Venkat R. K. Yedavalli, Jean‐Marie Péloponèse, Kuan-Teh Jeang, Kunihiko Watanabe, Akiko Miyazato, Kunio Tsurugi and Kazuhisa Kitamura and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Hidekatsu Iha

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidekatsu Iha Japan 20 546 528 249 232 190 49 1.2k
Kathleen L. McGuire United States 22 502 0.9× 405 0.8× 130 0.5× 135 0.6× 339 1.8× 40 1.2k
Chi‐Ming Liang Taiwan 19 221 0.4× 387 0.7× 61 0.2× 131 0.6× 148 0.8× 31 942
Ling‐Jun Zhao United States 23 480 0.9× 971 1.8× 97 0.4× 101 0.4× 211 1.1× 62 1.9k
Urban Ramstedt United States 21 732 1.3× 337 0.6× 196 0.8× 206 0.9× 149 0.8× 40 1.4k
Neelam Sharma United States 17 241 0.4× 450 0.9× 82 0.3× 78 0.3× 121 0.6× 31 824
Ana Urzainqui Spain 22 545 1.0× 898 1.7× 32 0.1× 54 0.2× 199 1.0× 40 1.8k
Chang‐Hyun Kim South Korea 21 360 0.7× 483 0.9× 35 0.1× 26 0.1× 176 0.9× 43 992
Qiang Hou China 19 167 0.3× 587 1.1× 47 0.2× 94 0.4× 193 1.0× 59 1.1k
Todd P. Knutson United States 24 349 0.6× 607 1.1× 45 0.2× 146 0.6× 495 2.6× 51 1.9k
Hiroshi Amanuma Japan 21 304 0.6× 852 1.6× 45 0.2× 56 0.2× 205 1.1× 67 1.6k

Countries citing papers authored by Hidekatsu Iha

Since Specialization
Citations

This map shows the geographic impact of Hidekatsu Iha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidekatsu Iha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidekatsu Iha more than expected).

Fields of papers citing papers by Hidekatsu Iha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidekatsu Iha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidekatsu Iha. The network helps show where Hidekatsu Iha may publish in the future.

Co-authorship network of co-authors of Hidekatsu Iha

This figure shows the co-authorship network connecting the top 25 collaborators of Hidekatsu Iha. A scholar is included among the top collaborators of Hidekatsu Iha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidekatsu Iha. Hidekatsu Iha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yu, Yoshiyuki Tsukamoto, Mitsuo Hori, & Hidekatsu Iha. (2024). Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL). International Journal of Molecular Sciences. 25(13). 7156–7156. 7 indexed citations
3.
Ichikawa, Tomonaga, Shingo Nakahata, Hidekatsu Iha, et al.. (2024). Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma. International Journal of Molecular Sciences. 25(5). 2842–2842. 2 indexed citations
4.
Wang, Yu, Hidekatsu Iha, Junichi Yamamoto, et al.. (2024). IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors. Frontiers in Oncology. 13. 1272528–1272528. 1 indexed citations
6.
Mori, Daisuke, et al.. (2022). Seroepidemiological survey of the prevalence of Helicobacter pylori infection in Sabah, Malaysia. IJID Regions. 2. 126–129. 2 indexed citations
7.
Ichikawa, Tomonaga, Shingo Nakahata, Masaya Ono, et al.. (2019). Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(2). 118615–118615. 11 indexed citations
8.
Ichikawa, Tomonaga, Shingo Nakahata, Masahiro Fujii, et al.. (2019). The regulation of NDRG2 expression during ATLL development after HTLV-1 infection. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(10). 2633–2646. 9 indexed citations
9.
Matsumoto, Takashi, et al.. (2017). Antiobesity and Anti‐Inflammatory Effects of Orally Administered Bonito Extracts on Mice Fed a High‐Fat Diet. Evidence-based Complementary and Alternative Medicine. 2017(1). 9187167–9187167. 2 indexed citations
10.
Mori, Daisuke, et al.. (2017). Increased serum vascular endothelial growth factor is associated with acute viral encephalitis in Bangladeshi children. Scientific Reports. 7(1). 16181–16181. 4 indexed citations
11.
Hijiya, Naoki, Tomotaka Shibata, Tsutomu Daa, et al.. (2016). Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis. Pathology International. 67(2). 83–90. 17 indexed citations
12.
Matsumoto, Takashi, Kentaro Yamada, Seiji Shiota, et al.. (2013). Passive carriage of rabies virus by dendritic cells. SpringerPlus. 2(1). 419–419. 7 indexed citations
14.
Shiota, Seiji, Kazuaki Mannen, Takashi Matsumoto, et al.. (2009). Development and evaluation of a rapid neutralizing antibody test for rabies. Journal of Virological Methods. 161(1). 58–62. 30 indexed citations
15.
Iha, Hidekatsu, Jean‐Marie Péloponèse, Lynn Verstrepen, et al.. (2008). Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation. The EMBO Journal. 27(4). 629–641. 127 indexed citations
16.
Shen, Hua, et al.. (2006). The mechanism by which overexpression of Gts1p induces flocculation in aFLO8-inactive strain of the yeastSaccharomyces cerevisiae. FEMS Yeast Research. 6(6). 914–923. 10 indexed citations
17.
Iha, Hidekatsu, Karen V. Kibler, Venkat R. K. Yedavalli, et al.. (2003). Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling. Oncogene. 22(55). 8912–8923. 50 indexed citations
18.
Kasai, Takefumi, Yoichi Iwanaga, Hidekatsu Iha, & Kuan‐Teh Jeang. (2002). Prevalent Loss of Mitotic Spindle Checkpoint in Adult T-cell Leukemia Confers Resistance to Microtubule Inhibitors. Journal of Biological Chemistry. 277(7). 5187–5193. 98 indexed citations
19.
Ng, Patrick, Hidekatsu Iha, Yoichi Iwanaga, et al.. (2001). Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation. Oncogene. 20(33). 4484–4496. 91 indexed citations
20.
Iha, Hidekatsu, Takefumi Kasai, Karen V. Kibler, et al.. (2000). Pleiotropic Effects of HTLV Type 1 Tax Protein on Cellular Metabolism: Mitotic Checkpoint Abrogation and NF- κ B Activation. AIDS Research and Human Retroviruses. 16(16). 1633–1638. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026